Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.329,29
-0,46%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Nuo Therapeutics Inc (QB) (AURX) Nuo Therapeutics Inc (QB) (AURX) Notizie

AURX

Nuo Therapeutics (QB) (AURX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:AURX
DataOraFonteTitoloSimboloCompagnia
11/06/202422:26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
22/05/202418:40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202423:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
14/02/202419:58Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:AURXNuo Therapeutics Inc (QB)
12/02/202423:33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
20/12/202320:18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202315:37Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202323:10Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/202312:08Edgar (US Regulatory)Annual Report (10-k)USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202200:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202214:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202214:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:AURXNuo Therapeutics Inc (QB)
30/08/202214:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AURXNuo Therapeutics Inc (QB)
10/08/202219:29Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202214:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202214:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AURXNuo Therapeutics Inc (QB)
19/05/202222:35Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:AURXNuo Therapeutics Inc (QB)
27/04/202222:20Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:AURXNuo Therapeutics Inc (QB)
31/03/202222:47Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:AURXNuo Therapeutics Inc (QB)
21/03/202215:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)USOTC:AURXNuo Therapeutics Inc (QB)
04/02/202223:03Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)USOTC:AURXNuo Therapeutics Inc (QB)
21/01/202217:29Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)USOTC:AURXNuo Therapeutics Inc (QB)
09/10/202021:30Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:AURXNuo Therapeutics Inc (QB)
13/11/201922:32Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/201922:21Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:AURXNuo Therapeutics Inc (QB)
04/08/201722:02Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:AURXNuo Therapeutics Inc (QB)
30/06/201723:25Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:AURXNuo Therapeutics Inc (QB)
20/04/201720:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:AURXNuo Therapeutics Inc (QB)
11/04/201712:17Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:AURXNuo Therapeutics Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:AURX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network